An Immunogenicity and Safety Study of Modified TRC-ID Regimen With A New Chromatographically Purified Vero Cell Rabies Vaccine(SPEEDA/TRCS SPEEDA) and Rabies Immunoglobulin.
Phase of Trial: Phase IV
Latest Information Update: 29 Nov 2016
At a glance
- Drugs Rabies vaccine (Primary) ; Rabies immune globulin
- Indications Rabies
- Focus Pharmacodynamics
- 23 Nov 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 23 Nov 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2018.
- 19 Oct 2015 Planned End Date changed from 1 Feb 2013 to 1 Dec 2017 as reported by the ClinicalTrials.gov record.